Stereotactic ablative radiotherapy (SABR) offers patients with early-stage non-small cell lung cancer (NSCLC) an effective alternative to the standard of care surgery — with significantly fewer severe ...

Adding immunotherapy to chemotherapy before surgery for patients with operable non-small cell lung cancer—the leading cause of cancer deaths worldwide—improved long-term survival overall compared with ...

Black patients with early-stage lung cancer were less likely to receive curative treatment than White patients, despite all having Medicare coverage, study finds. Dr. Olivia Lynch, a postdoctoral ...

Surgery is a common treatment for non-small cell lung cancer (NSCLC), particularly when the disease is detected early and the tumor is small and is only in one part of the lung. For small cell lung ...

SAN FRANCISCO, September 29, 2025 — A new clinical trial report finds that stereotactic radiation therapy offers long-term survival outcomes comparable to surgery for patients with small, early-stage ...

For patients with locally advanced non–small cell lung cancer (NSCLC), multidisciplinary team input optimizes outcomes by tailoring patient care, which is especially important during this era of ...

Amini: I believe this is critical for all stages of NSCLC. Whether you are in a small rural practice, large community or ...

HER2-mutated non-small-cell lung cancer (NSCLC) is a rare form of lung cancer where the cancer cells have a mutation that makes them grow and divide in an uncontrolled way. You can best understand ...

Lung cancer surgery is the primary form of treatment for most cases of early stage lung cancer. Surgery is particularly effective in cases where the tumor hasn’t spread. It can help treat the cancer, ...